12 July 2013
Available Conference Papers:
Targeting multi-protein regulatory systems: Allostery and proteinprotein interactions, Tom Blundell, University of Cambridge
Phenotypic vs target screening approaches – black or white or shades of grey, Graeme Walker, AstraZeneca
Selection and validation of cancer drug targets: Objective computational assessment and chemical tools, Paul Workman, The Institute of Cancer Research, London
The genomics of drug sensitivity in cancer: preclinical biomarker discovery in cancer cells, Mathew Garnett, Sanger Institute
Mode of action analysis and biomarker discovery by phosphoproteomics, Christian Eckert, Evotec, Germany
Visit Blog